| [1] | Xingtong LI, Taicheng ZHOU. Molecular mechanisms of the interaction between hepatitis B virus infection and mitochondrial homeostasis[J]. Journal of Clinical Hepatology, 2025, 41(2): 343-348. doi: 10.12449/JCH250222 |
| [2] | Hepatology International｜Functional B cell deficiency promotes intrahepatic HBV replication and impairs the development of anti-HBV T cell responses[J]. Journal of Clinical Hepatology, 2024, 40(12): 2360-2360. doi: 10.12449/JCH2412.gwqkjpwzjj1 |
| [3] | Yufeng XING, Zhiyi HAN, Daqiao ZHOU, Guangdong TONG. Research advances in kidney-tonifying therapy for patients with HBeAg-positive chronic HBV infection[J]. Journal of Clinical Hepatology, 2023, 39(6): 1267-1273. doi: 10.3969/j.issn.1001-5256.2023.06.002 |
| [4] | Hepatology International｜Analysis of viral integration reveals new insights of oncogenic mechanism in HBV-infected intrahepatic cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma[J]. Journal of Clinical Hepatology, 2023, 39(1): 21-21. doi: 10.3969/j.issn.1001-5256.2023.01.gwjpwzjj1 |
| [5] | Hepatology International｜Messenger RNA electroporated hepatitis B virus (HBV) antigen-specific T cell receptor (TCR) redirected T cell therapy is well-tolerated in patients with recurrent HBV-related hepatocellular carcinoma post-liver transplantation: results from a phase I trial[J]. Journal of Clinical Hepatology, 2023, 39(10): 2431-2431. doi: 10.3969/j.issn.1001-5256.2023.10.gwjpwzjj1 |
| [6] | Hepatology International｜Effects of antiviral therapy and drug withdrawal on postpartum hepatitis in pregnant women with chronic HBV infection[J]. Journal of Clinical Hepatology, 2023, 39(5): 1143-1143. doi: 10.3969/j.issn.1001-5256.2023.05.gwjpwzjj2 |
| [7] | Yang MAN, Zhiyi LIN, Zhang MIAO, Lerong YAN, Xiao CHENG, Renyi JING, Rong BAI, Pingwen HUANG, Hongwei ZHANG, Xinyu PENG. Comorbidity of hepatic cystic echinococcosis with HBV/HCV infection, liver cirrhosis, and hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2022, 38(3): 601-605. doi: 10.3969/j.issn.1001-5256.2022.03.020 |
| [8] | Hepatology｜Macrophage-specific fibroblast growth factor 12 promotes liver fibrosis progression in mice[J]. Journal of Clinical Hepatology, 2022, 38(8): 1885-1885. doi: 10.3969/j.issn.1001-5256.2022.08.gwjpwzjj2 |
| [9] | Journal of Hepatology｜Interruption of bile acid uptake by hepatocytes after acetaminophen overdose ameliorates hepatotoxicity[J]. Journal of Clinical Hepatology, 2022, 38(4): 890-890. doi: 10.3969/j.issn.1001-5256.2022.04.gwjpwzjj2 |
| [10] | Journal of Hepatology｜Impact of HBsAg seroclearance on late recurrence of hepatitis B virus-related hepatocellular carcinoma after surgical resection[J]. Journal of Clinical Hepatology, 2022, 38(12): 2727-2727. doi: 10.3969/j.issn.1001-5256.2022.12.gwjpwzjj1 |
| [11] | Journal of Hepatology｜PKCα/ZFP64/CSF1 axis resets the tumor microenvironment and fuels anti-PD1 resistance in hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2022, 38(3): 698-698. doi: 10.3969/j.issn.1001-5256.2022.3.gwjpwzjj2 |
| [12] | Hepatology International｜Diabetes is associated with the poor short-term prognosis of patients with HBV-related acute-on-chronic liver failure[J]. Journal of Clinical Hepatology, 2022, 38(2): 432-432. doi: 10.3969/j.issn.1001-5256.2022.02.gwjpwzjj7 |
| [13] | Wu ZhiHui, Yang MiaoMiao, Tu ZhengKun. Role of hepatitis B virus-induced myeloid-derived suppressor cell subsets in chronic HBV infection[J]. Journal of Clinical Hepatology, 2019, 35(12): 2783-2787. doi: 10.3969/j.issn.1001-5256.2019.12.030 |
| [14] | Chen WeiXia, Wang Lei, Liu Yang, Ji Guang, Xing LianJun. Expression of dendritic cell subsets in patients with different stages of chronic HBV infection:a comparative analysis[J]. Journal of Clinical Hepatology, 2017, 33(3): 458-461. doi: 10.3969/j.issn.1001-5256.2017.03.012 |
| [15] | Yang ZhiBin, Chen Qing, Ma ShiWu. Hot topics in nephropathy with HBV infection[J]. Journal of Clinical Hepatology, 2017, 33(12): 2416-2420. doi: 10.3969/j.issn.1001-5256.2017.12.037 |
| [16] | Wang YueJiao, Song HaiYan, Xing LianJun, Ji Guang, Zheng PeiYong. Pathogenesis of hepatocellular carcinoma induced by HBV and HCV infection[J]. Journal of Clinical Hepatology, 2017, 33(7): 1381-1386. doi: 10.3969/j.issn.1001-5256.2017.07.040 |
| [17] | Fang He, Jin Xiong, Wang DongDong, Liu Hong, Ma LinJie, Li Li, Hu ZongQiang. Research progress in culture and in vivo and in vitro HBV infection of primary hepatocytes of tree shrews[J]. Journal of Clinical Hepatology, 2015, 31(10): 1740-1743. doi: 10.3969/j.issn.1001-5256.2015.09.10.049 |
| [18] | Ren MeiXin, Meng QingHua. Research progress in mechanism of coexistence of HBsAg and HBsAb in patients with HBV infection[J]. Journal of Clinical Hepatology, 2014, 30(4): 375-378. doi: 10.3969/j.issn.1001-5256.2014.04.023 |
| [19] | Dong Jie, Shen HuanJun, Yang XiaoFei, Zhao RongRong, Zhang Ye, Zhao YanYan, Huang ZhangXing, Lian JianQi. Research progress in TIM-3 and HBV infection[J]. Journal of Clinical Hepatology, 2014, 30(9): 935-938. doi: 10.3969/j.issn.1001-5256.2014.09.025 |
| [20] | Min Jie, Feng YingMing, Zhang HeLong, Ji TongLi, Li Gang. Influence of HBV inflection on biological behaviours of hepatocellular carcinoma (HCC) and expression of p53 protein.[J]. Journal of Clinical Hepatology, 2006, 22(2): 131-133. |
DownLoad: